Pipeline™ vantage embolization device with shield technology™

Medtronic is initiating a recall of Pipeline™ Vantage devices with the part numbers PED3-027-XXX-XX, which represents compatibility to 0.027 inch (0.69 mm) inner diameter (id) microcatheters ["Pipeline™ Vantage 027"]. Additionally, Medtronic is issuing a correction to the IFY of pipeline vantage devices with the part number PED3-021-XXX-XX, which represents compatibility to 0.021 inch (0.53 mm) inner diameter (id) microcatheters ["Pipeline™ Vantage 021"]. Medtronic has received reports of incomplete wall apposition and/or braid deformation noted during the procedure and post procedure involving the Pipeline™ Vantage 027 and Pipeline™ Vantage 021 devices. Braid deformation (sometimes termed "fishmouthing", "braid narrowing", or "braid collapse") and incomplete wall apposition are known risks that potentially can lead to thrombosis and/or serious adverse events including stroke or death. As of 31 December 2024, Medtronic has received reports of incomplete wall apposition and/or braid deformation, including 3 patient deaths and 13 ischemic strokes (from 416 complaints out of approximately 18,200 Pipeline™ Vantage 027 units distributed worldwide). Pipeline™ Vantage 027 devices (diameters ≥4mm) appear to exhibit a higher incidence stent braid deformation compared to the pipeline shield. Additionally, the risk of braid deformation was higher in females, especially females ≤45 years of age. The risk of braid deformation presents either intra-operatively or post-procedurally, with braid deformations typically noted at 6-12-month imaging follow-up. Comparatively, for Pipeline™ Vantage 021 devices, fewer reports were received for incomplete wall apposition and/or braid deformation with 0 deaths and 4 strokes (from 57 complaints out of approximately 7,400 units distributed). The Pipeline™ Vantage 021 compatible sizes are similar to the pipeline shield product family in design characteristics. The rate of braid deformation for the Pipeline™ Vantage 021 is lower than that observed for Pipeline™ Vantage 027. Based on this information, the removal (retrieval) is only isolated unused inventory of the Pipeline™ Vantage 027 devices. As part of this recall, Medtronic will correct the IFU of the Pipeline™ Vantage 021 to provide instructions to users on mitigating the risk of incomplete wall apposition and/or braid deformation. Recall start date: January 30, 2025

Compare the product name and identifiers below with the item you own. Follow the official notice if they match.

The source does not list specific retailers. See the official notice for where affected products were sold.

Brand: Micro Therapeutics Dba Ev3 Neurovascular, Pipeline™ Vantage Embolization Device With Shield Technology™.